Pnc Financial Services Group, Inc. Tyra Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 58 shares of TYRA stock, worth $542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58
Previous 58
-0.0%
Holding current value
$542
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$99.5 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$38.8 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$38.2 Million90.83% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$37.9 Million8.77% of portfolio
-
Nextech Invest Ag4.06MShares$37.9 Million10.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $392M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...